Stryker Corporation $SYK Stock Position Increased by Vest Financial LLC

Vest Financial LLC boosted its position in Stryker Corporation (NYSE:SYK) by 17.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 642 shares of the medical technology company’s stock after purchasing an additional 97 shares during the quarter. Vest Financial LLC’s holdings in Stryker were worth $254,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of SYK. Sachetta LLC lifted its position in Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 27 shares during the last quarter. Goodman Advisory Group LLC bought a new stake in Stryker in the 1st quarter valued at about $32,000. Ridgewood Investments LLC lifted its position in Stryker by 48.4% in the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares during the last quarter. Ransom Advisory Ltd bought a new stake in shares of Stryker during the 1st quarter worth about $37,000. Finally, Smallwood Wealth Investment Management LLC bought a new stake in shares of Stryker during the 1st quarter worth about $40,000. 77.09% of the stock is currently owned by institutional investors.

Insider Activity at Stryker

In related news, insider Viju Menon sold 500 shares of the business’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the transaction, the insider directly owned 12,511 shares of the company’s stock, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. The trade was a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have commented on SYK shares. Redburn Partners set a $420.00 price target on shares of Stryker in a research report on Thursday, September 18th. BTIG Research boosted their price target on shares of Stryker from $407.00 to $408.00 and gave the stock a “buy” rating in a research report on Monday. Wells Fargo & Company boosted their price target on shares of Stryker from $435.00 to $445.00 and gave the stock an “overweight” rating in a research report on Friday, August 1st. Wall Street Zen downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. Finally, Rothschild & Co Redburn started coverage on shares of Stryker in a research report on Thursday, September 18th. They set a “neutral” rating and a $420.00 price target on the stock. Fifteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, Stryker presently has an average rating of “Moderate Buy” and an average price target of $431.76.

Stryker Stock Down 0.1%

Shares of NYSE:SYK opened at $369.60 on Thursday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The company has a market cap of $141.30 billion, a PE ratio of 48.95, a price-to-earnings-growth ratio of 2.67 and a beta of 0.94. Stryker Corporation has a 52 week low of $329.16 and a 52 week high of $406.19. The firm has a 50 day simple moving average of $379.60 and a 200 day simple moving average of $378.78.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, beating the consensus estimate of $3.07 by $0.06. The business had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, research analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s dividend payout ratio is 44.50%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.